☆ 4.7 Letter

Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations

JOURNAL OF CLINICAL ONCOLOGY (2008)

Get Full Text
Add to Collection

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 26, Issue 7, Pages 1182-1184

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2007.14.9039

Keywords

-

Categories

Oncology

Funding

  1. NATIONAL CANCER INSTITUTE [P50CA090578] Funding Source: NIH RePORTER
  2. NCI NIH HHS [P50 CA090578] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.